Inflammation Stocks List Ranked for 2024 | NYSE,

Inflammation ETFs
Recent Inflammation News

Symbol	Grade	Name	% Change
VTVT	C	vTv Therapeutics Inc.	0.07
ROIV	B	Roivant Sciences Ltd.	-1.58
REGN	C	Regeneron Pharmaceuticals, Inc.	1.48
QTRX	F	Quanterix Corporation	-0.06
PFE	D	Pfizer, Inc.	-0.97
OPTN	F	OptiNose, Inc.	-2.33
OMER	D	Omeros Corporation	4.23
OLK	C	Olink Holding AB	0.00
OCUP	F	Ocuphire Pharma, Inc.	-2.88
OCUL	D	Ocular Therapeutix, Inc.	-1.59

View As Page of Charts

Related ETFs - A few ETFs which own one or more of the above listed Inflammation stocks.

Symbol	Grade	Name	Weight
HDLB	C	ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044	13.4
PJP	A	PowerShares Dynamic Pharmaceuticals	11.75
FTXH	D	First Trust Nasdaq Pharmaceuticals ETF	11.59
IBB	D	iShares Nasdaq Biotechnology Index Fund	9.22
IBBQ	C	Invesco Nasdaq Biotechnology ETF	8.23

View all Inflammation ETFs...

Compare ETFs

Compare HDLB to IBB Compare IBB to IBBQ Compare PJP to IBBQ

Inflammation Stocks Recent News

Date	Stock	Title
May 18	PFE	Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18	OPTN	OptiNose, Inc. (OPTN) Q1 2024 Earnings Call Transcript
May 17	PFE	4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
May 17	PFE	European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
May 17	REGN	More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
May 17	PFE	Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
May 17	PFE	Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
May 17	PFE	Pfizer Stock: Rebound Has Started (Technical Analysis)
May 17	OPTN	Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 17	REGN	Regeneron wins temporary restraining order preventing Eylea generic launch
May 17	PFE	Pfizer: Potential Double-Digit Upside Combined With High Dividend Yield
May 16	ROIV	Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
May 16	OMER	Q1 2024 Omeros Corp Earnings Call
May 16	OMER	Omeros plunges 20% following Q1 report, drug update
May 16	PFE	Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16	PFE	2 Top Growth Stocks Down 24% and 50% to Buy With $100
May 16	REGN	These 2 No-Brainer Growth Stocks Are Breaking New Ground
May 16	PFE	Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16	PFE	Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report
May 16	OMER	Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...

Inflammation: Inflammation is part of the complex biological response of body tissues to harmful stimuli, such as pathogens, damaged cells, or irritants, and is a protective response involving immune cells, blood vessels, and molecular mediators. The function of inflammation is to eliminate the initial cause of cell injury, clear out necrotic cells and tissues damaged from the original insult and the inflammatory process, and initiate tissue repair.

More about Inflammation

Browse All Tags